Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Constrained numerical deconvolution using orthogonal polynomials.

Heliyon·2024
Same author

Whole body physiologically based modelling of β-blockers in the rat: events in tissues and plasma following an i.v. bolus dose.

British journal of pharmacology·2017
Same author

Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas.

CPT: pharmacometrics & systems pharmacology·2017
Same author

Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future.

Clinical pharmacology and therapeutics·2017
Same author

Mathematical model of T-cell lymphoblastic lymphoma: disease, treatment, cure or relapse of a virtual cohort of patients.

Mathematical medicine and biology : a journal of the IMA·2017
Same author

Identification of the effect of multiple polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid using a population-modeling approach.

Clinical pharmacology and therapeutics·2014
Same journal

Titanium dioxide food additive (E171) and zinc oxide nanoparticles alter coagulation markers in endothelial cells and activate platelets.

Environmental toxicology and pharmacology·2026
Same journal

Carbendazim Detection in Human Follicular Fluid: Impact on Human Granulosa Cell Function (KGNs and primary cells) and Mouse Ovarian Physiology.

Environmental toxicology and pharmacology·2026
Same journal

Metabolic perturbations underlying the associations of non-persistent organic pollutant mixtures with blood pressure: A panel study in adults.

Environmental toxicology and pharmacology·2026
Same journal

Arsenic exposure disrupts human hematopoiesis by impairing the generation and function of hematopoietic stem and progenitor cells.

Environmental toxicology and pharmacology·2026
Same journal

Effects of beta-cypermethrin on the antioxidant system and gut microbiota in Eisenia fetida.

Environmental toxicology and pharmacology·2026
Same journal

Urban particulate matter impairs human epidermal keratinocyte biology via the TRPV1-mitochondrial axis and TRPV1-Notch signaling.

Environmental toxicology and pharmacology·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

Parallel High Throughput Single Molecule Kinetic Assay for Site-Specific DNA Cleavage
06:51

Parallel High Throughput Single Molecule Kinetic Assay for Site-Specific DNA Cleavage

Published on: May 6, 2020

Population approaches/sparse data analysis for human variability in kinetics and dynamics.

L Aarons

    Environmental Toxicology and Pharmacology
    |July 26, 2011
    PubMed
    Summary
    This summary is machine-generated.

    Sparse data analysis, or the population approach, helps assess drug variability. New software enables analysis of complex clinical trial data, guiding dosage for better therapeutic outcomes.

    More Related Videos

    High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy
    15:13

    High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy

    Published on: July 25, 2014

    Study of Protein Dynamics via Neutron Spin Echo Spectroscopy
    08:03

    Study of Protein Dynamics via Neutron Spin Echo Spectroscopy

    Published on: April 13, 2022

    Related Experiment Videos

    Last Updated: May 30, 2026

    Parallel High Throughput Single Molecule Kinetic Assay for Site-Specific DNA Cleavage
    06:51

    Parallel High Throughput Single Molecule Kinetic Assay for Site-Specific DNA Cleavage

    Published on: May 6, 2020

    High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy
    15:13

    High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy

    Published on: July 25, 2014

    Study of Protein Dynamics via Neutron Spin Echo Spectroscopy
    08:03

    Study of Protein Dynamics via Neutron Spin Echo Spectroscopy

    Published on: April 13, 2022

    Area of Science:

    • Pharmacology
    • Pharmacometrics
    • Clinical Pharmacology

    Background:

    • Pharmacokinetic and pharmacodynamic (PK/PD) variability is crucial in drug development.
    • Traditional analysis methods struggle with heterogeneous and sparse data common in clinical trials.

    Purpose of the Study:

    • To review the application of sparse data analysis techniques (population approach) for PK/PD variability assessment.
    • To highlight the utility of newly available software for analyzing sparse clinical trial data.

    Main Methods:

    • Review of sparse data analysis techniques, specifically the population approach.
    • Utilizing recently developed software capable of analyzing heterogeneous, sparse data from clinical trials.

    Main Results:

    • Sparse data analysis allows for the study of PK and PD in the target population.
    • This approach facilitates the analysis of complex datasets previously difficult to manage.

    Conclusions:

    • The population approach, leveraging new software, enables robust PK/PD variability assessment.
    • This methodology aids in optimizing drug dosage for improved therapeutic benefits during drug development.